From: Identification and validation of a pyroptosis-related prognostic signature for thyroid cancer
Variables | Univariate analysis | Multivariate analysis | ||||||
---|---|---|---|---|---|---|---|---|
HR | HR.95L | HR.95H | P | HR | HR.95L | HR.95H | P | |
Training set | Â | Â | Â | Â | Â | Â | Â | |
 Age | 1.16 | 1.07 | 1.25 | 0.00 | 1.16 | 1.06 | 1.26 | 0.00 |
 Gender | 0.50 | 0.06 | 4.15 | 0.52 | 0.50 | 0.06 | 4.57 | 0.54 |
 Stage | 3.20 | 1.42 | 7.18 | 0.00 | 2.65 | 0.91 | 7.74 | 0.07 |
 Riskscore | 5.58 | 1.24 | 25.11 | 0.03 | 15.80 | 1.25 | 199.28 | 0.03 |
Test set | Â | Â | Â | Â | Â | Â | Â | Â |
Age | 1.16 | 1.08 | 1.26 | 0.00 | 1.20 | 1.08 | 1.34 | 0.00 |
 Gender | 4.27 | 1.14 | 15.98 | 0.03 | 3.04 | 0.49 | 18.92 | 0.23 |
 Stage | 2.07 | 1.17 | 3.66 | 0.01 | 0.91 | 0.39 | 2.10 | 0.82 |
 Riskscore | 1.15 | 1.06 | 1.25 | 0.00 | 1.19 | 1.05 | 1.36 | 0.01 |
Entire set | Â | Â | Â | Â | Â | Â | Â | Â |
 Age | 1.16 | 1.10 | 1.22 | 0.00 | 1.17 | 1.11 | 1.25 | 0.00 |
 Gender | 1.92 | 0.69 | 5.30 | 0.21 | 1.09 | 0.33 | 3.60 | 0.88 |
 Stage | 2.42 | 1.53 | 3.80 | 0.00 | 1.49 | 0.81 | 2.75 | 0.20 |
 Riskscore | 1.15 | 1.06 | 1.24 | 0.00 | 1.20 | 1.09 | 1.32 | 0.00 |